[go: up one dir, main page]

MX379786B - Apósito para heridas o para la piel. - Google Patents

Apósito para heridas o para la piel.

Info

Publication number
MX379786B
MX379786B MX2018014124A MX2018014124A MX379786B MX 379786 B MX379786 B MX 379786B MX 2018014124 A MX2018014124 A MX 2018014124A MX 2018014124 A MX2018014124 A MX 2018014124A MX 379786 B MX379786 B MX 379786B
Authority
MX
Mexico
Prior art keywords
acid
pharmaceutical composition
wound
skin dressing
wound dressing
Prior art date
Application number
MX2018014124A
Other languages
English (en)
Other versions
MX2018014124A (es
Inventor
Annahit Arshi
Christian Schulze
Karsten Hemmrich
Original Assignee
Bsn Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bsn Medical Gmbh filed Critical Bsn Medical Gmbh
Publication of MX2018014124A publication Critical patent/MX2018014124A/es
Publication of MX379786B publication Critical patent/MX379786B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica y a este respecto en particular a un apósito para la piel o para heridas, que comprende un oligómero y/o un polímero que hidrolizan de manera ácida y un profármaco que puede activarse con ácido, de modo que en la composición farmacéutica o bien en el apósito para la piel o para heridas se forma el principio activo mediante acción de ácidos a partir del profármaco. La invención se refiere además a un correspondiente procedimiento para la liberación de principios activos de una composición farmacéutica.
MX2018014124A 2016-05-17 2017-05-15 Apósito para heridas o para la piel. MX379786B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16169905.3A EP3246050A1 (de) 2016-05-17 2016-05-17 Wund- oder hautauflage
PCT/EP2017/061587 WO2017198603A1 (de) 2016-05-17 2017-05-15 Wund- oder hautauflage

Publications (2)

Publication Number Publication Date
MX2018014124A MX2018014124A (es) 2019-07-04
MX379786B true MX379786B (es) 2025-03-11

Family

ID=56068693

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018014124A MX379786B (es) 2016-05-17 2017-05-15 Apósito para heridas o para la piel.

Country Status (9)

Country Link
US (1) US11389559B2 (es)
EP (2) EP3246050A1 (es)
CN (1) CN109152860B (es)
AU (1) AU2017267176B2 (es)
BR (1) BR112018073703B1 (es)
CO (1) CO2018012346A2 (es)
MX (1) MX379786B (es)
WO (1) WO2017198603A1 (es)
ZA (1) ZA201808318B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
JP6151186B2 (ja) 2010-12-08 2017-06-21 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 創傷滲出液システム付属装置
EP4162968A1 (en) 2010-12-08 2023-04-12 ConvaTec Technologies Inc. System for removing exudates from a wound site
CA2819475C (en) 2010-12-08 2019-02-12 Convatec Technologies Inc. Integrated system for assessing wound exudates
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
CN105008611A (zh) 2012-12-20 2015-10-28 康沃特克科技公司 化学改性的纤维素纤维的处理
EP3386488B1 (en) 2015-12-08 2023-09-06 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
KR20190013725A (ko) 2016-03-30 2019-02-11 컨바텍 테크놀러지스 인크 상처 내의 미생물 감염의 검출
CA3019445A1 (en) 2016-03-30 2017-12-14 Synovo Gmbh Detecting microbial infection in wounds
AU2017268840B2 (en) * 2016-05-27 2022-02-10 Lyndra Therapeutics, Inc. Materials architecture for gastric residence systems
AU2017292028B2 (en) 2016-07-08 2023-03-02 Convatec Technologies Inc. Fluid flow sensing
CN109640904A (zh) 2016-07-08 2019-04-16 康沃特克科技公司 流体收集设备
KR20190026858A (ko) 2016-07-08 2019-03-13 컨바텍 테크놀러지스 인크 가요성 부압 시스템
WO2018227147A1 (en) 2017-06-09 2018-12-13 Lyndra, Inc. Gastric residence systems with release rate-modulating films
EP3678544A4 (en) * 2017-09-05 2021-05-19 Breathevision Ltd. MONITORING SYSTEM
EP4360666A3 (en) 2017-11-16 2024-05-08 ConvaTec Limited Fluid collection apparatus
US11506658B2 (en) 2019-04-24 2022-11-22 Progenitec, Inc. System for analysis of body fluids and wound-associated biomolecules
WO2020245656A1 (en) 2019-06-03 2020-12-10 Convatec Limited Methods and devices to disrupt and contain pathogens
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
CN113018518B (zh) * 2021-03-05 2022-06-03 上海交通大学医学院附属新华医院 一种用于婴幼儿狭窄血管可吸收血管支架涂层的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888176A (en) 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4857311A (en) 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
US4997904A (en) 1989-08-25 1991-03-05 Nova Pharmaceutical Corporation Aromatic polyanhydride compositions
WO1991015260A1 (en) 1990-03-30 1991-10-17 Alza Corporation Device and method for iontophoretic drug delivery
US5264540A (en) 1992-07-20 1993-11-23 Ethicon, Inc. Aromatic polyanhydrides
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
DK174312B1 (da) 1996-06-06 2002-12-02 Ole Pedersen Fremgangsmåde til måling af strømningshastighed og diffusivitet, mikrosensor til brug ved fremgangsmåden samt anvendelse af sådan mikrosensor
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6706274B2 (en) * 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
WO2003006427A1 (en) 2001-07-12 2003-01-23 Johns Hopkins University Compounds that release nitric oxide at controlled rates upon photolysis
US6673338B1 (en) 2001-09-10 2004-01-06 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
US20030039697A1 (en) 2002-09-12 2003-02-27 Yi-Ju Zhao Matrices containing nitric oxide donors and reducing agents and their use
EP1737502B1 (en) * 2004-01-22 2014-01-15 The University of Akron Polymer no donor predrug nanofiber coating for medical devices
EP1827332A4 (en) 2004-11-29 2010-03-17 Univ Akron TOPICAL STAINED OXIDE DONATING DEVICES AND METHOD FOR THEIR THERAPEUTIC APPLICATION
US8071083B2 (en) * 2004-12-13 2011-12-06 Progentix Orthobiology B.V. Tissue regeneration
GB0505035D0 (en) * 2005-03-11 2005-04-20 Insense Ltd Improvements relating to skin dressings
CN1990045B (zh) * 2005-12-30 2010-12-22 北京尼奥克斯生物科技有限公司 一种新型高效烧烫伤类贴剂及其制备方法
EP2051935B1 (en) 2006-07-26 2016-09-07 STMicroelectronics Srl Use of nitroaniline derivatives for the production of nitric oxide
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
CN101873869A (zh) 2007-10-26 2010-10-27 国家免疫学研究所 可生物降解的聚合物支架及其制备方法
WO2009155690A1 (en) 2008-06-24 2009-12-30 Micropharma Limited Nitric oxide compositions and devices and methods for cosmesis
WO2014052443A1 (en) * 2012-09-28 2014-04-03 The Regents Of The University Of Michigan Sustained nitric oxide release coating using diazeniumdiolate-doped polymer matrix with ester capped poly(lactic-co-glycolic acid) additive
WO2016115448A1 (en) * 2015-01-15 2016-07-21 Marshall University Research Corporation Wound coverings comprising vitamin d and related methods

Also Published As

Publication number Publication date
EP3458115B1 (de) 2020-08-26
BR112018073703A2 (pt) 2019-02-26
WO2017198603A1 (de) 2017-11-23
CN109152860A (zh) 2019-01-04
ZA201808318B (en) 2019-08-28
EP3458115A1 (de) 2019-03-27
CO2018012346A2 (es) 2019-10-31
AU2017267176A1 (en) 2019-01-17
EP3246050A1 (de) 2017-11-22
BR112018073703B1 (pt) 2022-04-26
MX2018014124A (es) 2019-07-04
US11389559B2 (en) 2022-07-19
AU2017267176B2 (en) 2021-05-27
CN109152860B (zh) 2022-04-05
US20190290799A1 (en) 2019-09-26

Similar Documents

Publication Publication Date Title
MX379786B (es) Apósito para heridas o para la piel.
CL2018003173A1 (es) Sistema de administración de apósito para heridas mediante presión negativa
IL264413B (en) Preparations containing fibers obtained electrohydrodynamically for delivering specific doses of active substance to the skin or mucous membrane
BR112018067408A2 (pt) formas sólidas de um inibidor de acc de tienopirimidinadiona e métodos para a produção das mesmas
PT3383363T (pt) Formulações farmacêuticas tópicas para o tratamento de afeções relacionadas com inflamações
DK3258942T3 (da) Kosmetiske og topiske sammensætninger omfattende cannabigerol og cannabidiol
PT3773593T (pt) Tratamento da hidradenite supurativa com inibidores de jak
EA201791747A1 (ru) 3-алкил-4-амидобициклические [4,5,0] гидроксамовые кислоты в качестве ингибиторов hdac
BR112018001292A2 (pt) métodos para melhor liberação de agentes ativos a tumores
BR112018001435A2 (pt) métodos para entrega linfática de agentes ativos
MX2016011842A (es) Composiciones tópicas de corticosteroides.
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
MX2016013236A (es) Formulacion inmunosupresora.
EP3582813A4 (en) TREATMENT OF SUPPURATIVE HIDRADENITIS
AR104562A1 (es) Tratamiento de madera que provee estabilidad dimensional
MX2016014050A (es) Combinacion de un acido hialuronico y un polisacarido sulfatado.
CY1118214T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει palmitoylethanolamide και l-acetylcarnιτινε
CO7240418A2 (es) Apósito con una liberación prolongada de agentes activos
ECSP18018793A (es) Compuestos útiles para inhibir ror-gamma-t
CL2018002128A1 (es) Composiciones y métodos para el tratamiento de heridas crónicas
DK3308794T3 (da) Terapeutisk middel til sår eller ru hud
BR112017008867A2 (pt) inibidores de proteína quinases
GT201400146A (es) Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides
CL2012003209A1 (es) Metodo de sintesis de nanoparticulas de acido poli (lactico-glicolico) (plga) con pentoxifilina; composicion farmaceutica que comprende nanoparticulas de plga con pentoxifilina; y uso de las nanoparticulas de plga cargada con pentoxifilina en el tratamiento del alivio y prevencion del dolor cronico.
EP3582770A4 (en) CANNABINOID FORMULATIONS FOR THE TREATMENT OF ACNE